Engineered Ribosyl-1-Kinase Enables Concise Synthesis of Molnupiravir, an Antiviral for COVID-19

John A. McIntosh(Merck & Co., Inc., Rahway, NJ, USA (United States)), Patrick S. Fier(Merck & Co., Inc., Rahway, NJ, USA (United States)), Tamas Benkovics(Merck & Co., Inc., Rahway, NJ, USA (United States)), Steven M. Silverman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Hsing‐I Ho(Merck & Co., Inc., Rahway, NJ, USA (United States)), Artis Klapars(Merck & Co., Inc., Rahway, NJ, USA (United States)), Neil A. Strotman(Merck & Co., Inc., Rahway, NJ, USA (United States)), William Morris(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jongrock Kong(Merck & Co., Inc., Rahway, NJ, USA (United States)), Grant S. Murphy(Merck & Co., Inc., Rahway, NJ, USA (United States)), Weilan Pan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jonathan Vroom(Codexis (United States)), Jessica A. Hurtak(Codexis (United States)), Deeptak Verma(Merck & Co., Inc., Rahway, NJ, USA (United States)), Anna Fryszkowska(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mark A. Huffman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kevin M. Maloney(Merck & Co., Inc., Rahway, NJ, USA (United States)), Anders M. Knight(California Institute of Technology), Peter E. Maligres(Merck & Co., Inc., Rahway, NJ, USA (United States)), Tetsuji Itoh(Merck & Co., Inc., Rahway, NJ, USA (United States)), Hao Yang(Tongji University)
ACS Central Science
October 29, 2021
Cited by 197


Related Papers